Understanding the practical differences between injectable and oral administration helps match medication format to individual preferences and lifestyle factors
I am beyond thrilled and recommending these patches to all of my clients
also protects against UV-driven collagen degradation
Some people experience stomach upset, diarrhea, or nausea when they start
What We Know: Animal studies : Clear increased risk of medullary thyroid cancer in mice and rats Human studies : No definitive increased risk documented Real-world data : Thyroid cancer incidence in semaglutide users remains under 1% Clinical Implications: Avoid semaglutide in patients with: Personal history of medullary thyroid cancer Family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 (MEN2) Practical Clinical Considerations Patient Selection for Cancer Risk Reduction Consider discussing GLP-1 agonists with patients who have: High obesity-related cancer risk (strong family history, previous cancer) Multiple metabolic risk factors (diabetes, metabolic syndrome) Completed cancer treatment seeking recurrence prevention Counseling Points Emphasize to patients: Cancer risk reduction is a potential benefit , not a guaranteed outcome Weight loss and lifestyle changes remain fundamental to cancer prevention These medications are adjuncts to , not replacements for, proven cancer prevention strategies Long-term safety data is still evolving Monitoring Recommendations For patients on semaglutide: Baseline thyroid examination and family history review Monitor for thyroid symptoms : neck mass, hoarseness, difficulty swallowing Regular follow-up for medication tolerance and efficacy Continue standard cancer screening protocols The Bigger Picture While the cancer prevention data is encouraging, its important to maintain perspective
Connect with Dr
